Novel glucagon-like peptide-1 drugs designed for type 2 diabetes

Novel glucagon-like peptide-1 (GLP-1) drugs were designed and industrially prepared by researchers at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences through molecular design, strain construction, ...

Near-infrared synergy therapy for cancer nanoclusters

As a minimally-invasive method for cancer therapy at precise locations, NIR-induced photothermal therapy (PTT) has drawn extensively attention. The therapeutic mechanism is the use of photothermal agents (PTAs) in the treatment ...

Vibrating nanodroplets may invade a tumor

Sending tiny droplets to a tumor and having them vaporized using focused ultrasound: It could be a new way of tracing a tumor or deliver drugs locally. Researchers of the University of Twente now demonstrate a new phenomenon ...

Scientists find way to supercharge protein production

Medicines such as insulin for diabetes and clotting factors for hemophilia are hard to synthesize in the lab. Such drugs are based on therapeutic proteins, so scientists have engineered bacteria into tiny protein-making factories. ...

The extraordinary powers of bacteria visualized in real time

The global spread of antibiotic resistance is a major public health issue and a priority for international microbiology research. In a paper to be published in the journal Science, a team led by Christian Lesterlin, Inserm ...

page 1 from 2